GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference
Topics/Cirrhosis Liver/Post-Banding Ulcer Bleeding After EBL: Alimentary Pharmacology & Therapeutics | March 2026
37

Post-Banding Ulcer Bleeding After EBL: Alimentary Pharmacology & Therapeutics | March 2026

Clinical knowledge base written and curated by GastroAGI Team from primary medical literatureLast updated March 1, 2026

Introduction

Endoscopic band ligation (EBL) remains the standard of care for managing esophageal varices, both in acute variceal bleeding and for prophylaxis. However, post-banding ulcer bleeding (PBUB) is an important and often under-recognized complication, associated with significant morbidity and mortality. Identifying patients at higher risk for PBUB is clinically relevant, particularly in acute settings where outcomes are already compromised.

Problem Statement

Despite increasing recognition of PBUB, risk stratification remains inconsistent in clinical practice. Recent data have suggested that urgent EBL and renal dysfunction may increase PBUB risk, but real-world validation across larger cohorts is limited, and standardized definitions are lacking.

Summary

In this large real-world analysis of 920 EBL procedures, PBUB occurred in 3.4% overall, with a significantly higher incidence following urgent EBL compared to elective procedures (7.5% vs 1.4%). Urgent EBL emerged as a strong independent predictor of PBUB, reinforcing the vulnerability of patients undergoing intervention during acute bleeding episodes. Additionally, renal dysfunction was identified as a key risk factor, with patients having serum creatinine ≥1.5 mg/dL demonstrating markedly higher bleeding rates and independent risk. These findings are consistent with prior literature and highlight a simple, clinically applicable framework combining urgency of EBL and renal function to identify high-risk patients. This approach may help guide closer monitoring and preventive strategies in routine practice.

Related Q&A

38

Ammonia Measurement in Cirrhosis: Journal of Hepatology| March 2026

Introduction Ammonia has long been recognized as a central neurotoxin in the pathogenesis of hepatic encephalopathy, but its clinical use in cirrhosis has remained inconsistent because of major...

39

A-TANGO for ACLF: Journal of Hepatology | February 2026

Introduction Acute-on-chronic liver failure (ACLF) is a severe syndrome characterized by acute decompensation of cirrhosis, multiorgan failure, and high short-term mortality. The current EASL-CLIF criteria have been widely...

40

Ammonia Measurement in Cirrhosis: From ISHEN: J Hepatol | March 2026

Introduction Ammonia has long been recognised as a central neurotoxin in the pathogenesis of hepatic encephalopathy, but its clinical use in cirrhosis has remained inconsistent because of major...

41

GLP-1RA Improve Liver Outcomes in Patients With Alcohol Use: AJG, March 2026

Introduction Harmful alcohol use remains a major cause of chronic liver disease, cirrhosis, hepatocellular carcinoma (HCC), and liver-related mortality worldwide. Despite advances in hepatology care, effective pharmacologic strategies...

42

Early Portopulmonary Hypertension- J Heptol Feb.26

Portopulmonary hypertension (PoPH) is a serious but frequently underdiagnosed complication of cirrhosis and portal hypertension. Traditionally, attention has focused on advanced PoPH, while mild or “borderline” pulmonary hemodynamic...

43

UTOpiA: A New Direction for Bioartificial Liver Therapy- AJG Feb.26

Introduction Acute-on-chronic liver failure (ACLF) is one of the most lethal syndromes in hepatology, characterized by abrupt hepatic decompensation, intense systemic inflammation, multi-organ failure, and very high short-term...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer